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Background
Aggregation of Ab polypeptide plays an important role in
pathogenesis of Alzheimer’s disease, the most common
form of dementia [1]. Therapies based on rationally
designed aggregation inhibitors require knowledge of
molecular structure [2]; because of high aggregation ten-
dency of Ab, it has not been possible to obtain complete
structural information by X-ray crystallography. The
hydrophobic C-terminal part of the Ab peptide is critical
in triggering transformation from a-helical to b-sheet
structure. Phospholipases are an important enzyme
involved in the inflammatory cascade mechanism having
a conserved globular structure with active site, calcium
binding loop, and hydrophobic channel. It has been
speculated that phospholipase A2 (PLA2) inhibits the
aggregation of Ab peptide by interacting with the peptide
and keeping the two peptide chains apart.
Material and methods
PLA2 was purified to homogeneity from cobra venom.
In order to examine the nature of interactions between
PLA2 and Ab36-42 peptide 1:1 complex of PLA2 with the
C-terminal heptapeptide Val-Gly-Gly-Val-Val-Ile-Ala
was prepared and co-crystallized. It is in tetragonal
space group P41 with unit cell dimensions, a=b=42.6 Å,
c=65.8Å. X-ray intensity data were collected to 2.04 Å
resolution. Structure has been determined by molecular
replacement and refined to the crystallographic R factor
of 0.193. Structural co-ordinates were deposited at
RCSB’s PDB (3GCI).
Results
Peptide binds to PLA2 at the hydrophobic substrate bind-
ing site and forms at least eight hydrogen bonds and
about a two dozen Van der Waals interactions indicating
that the affinity between PLA2 and the heptapeptide is
far greater than the affinity between two Ab peptide
chains. Therefore, PLA2 may have a potential role to pre-
vent the aggregation of Ab peptides. Calcium has been
found in the calcium binding site and has pentagonal
bipyramidal geometry. Kinetic studies showed that the
peptide VGGVVIA binds to PLA2 in a competitive man-
ner with a binding constant of 5.2 x 10-7 M.
Conclusions
This is the first attempt to structurally establish the inter-
action between Ab peptide and PLA2. Results indicate
that the peptide mainly adopts b-sheet secondary struc-
ture. Understanding the mechanism and effects of PLA2
upregulation in AD brain may help in the development
of novel strategies to inhibit the inflammatory responses
and delay AD progression. Preventing the folding of nas-
cent Ab monomer into toxic conformers or oligomers
would have therapeutic benefits.
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